TYPE 1 (SUB-RETINAL PIGMENT EPITHELIAL) NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY MASQUERADING AS NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology,General Medicine
Reference44 articles.
1. Do we need a new classification for choroidal neovascularization in age-related macular degeneration R;Freund;etina,2010
2. Central serous chorioretinopathy: a personal perspective.;Yannuzzi;Am J Ophthalmol,2010
3. . Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy.;Loo;Retina,2002
4. Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy.;Konstantinidis;Eur J Ophthalmol,2010
5. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.;Chan;Am J Ophthalmol,2007
Cited by 194 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Central serous chorioretinopathy: An evidence-based treatment guideline;Progress in Retinal and Eye Research;2024-02
2. Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-01-31
3. Intravitreal Brolucizumab for Pachychoroid Neovasculopathy Associated With Chronic Central Serous Chorioretinopathy;Translational Vision Science & Technology;2023-12-19
4. Characteristics Related to Visual Acuity Loss After Successful Photodynamic Therapy for Eyes With Central Serous Chorioretinopathy;American Journal of Ophthalmology;2023-12
5. Subretinal hyperreflective material (SHRM) in retinal and chorioretinal disorders: A comprehensive review;Survey of Ophthalmology;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3